More than a decade has passed since the two companies began their courtship. Finally, they have tied the knot. Beginning Oct. 19, telephone operators at Marconi Medical Systems began answering calls as Philips Medical Systems—formerly Marconi. The
More than a decade has passed since the two companies began their courtship. Finally, they have tied the knot. Beginning Oct. 19, telephone operators at Marconi Medical Systems began answering calls as Philips Medical Systems-formerly Marconi. The deal between the two companies was finalized when U.S. regulators agreed the union would not be anticompetitive.
European regulators had come to the same conclusion several days earlier. The takeover paves the way for Philips to become a contender in super premium CT, the weakest link in that company’s radiological armor. The $1.1 billion cash deal caps a multibillion-dollar three-year acquisition program that has included the purchase by Philips of Agilent’s Healthcare Solutions Group, ADAC Laboratories, and ATL Ultrasound.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.